|Contact Information||Research Interests|
|Charles E. Wood, Ph.D.
Professor and Chair
|Abdel Alli, PhD, MPH
blood pressure disorders
|Kirk P. Conrad, M.D.
J. Robert and Mary Cade Professor of Physiology
|Cardiovascular and renal vasodilation, and increased arterial compliance during normal pregnancy
Cardiovascular and renal vasodilatory actions and mechanisms of relaxin
Corpus luteal contribution to pregnancy physiology and outcome in assisted reproductive technology
Trophoblast and placental biology
Endometrial antecedents of preeclampsia
|Annette de Kloet, Ph.D.
Stress and stress-related pathologies
Neural regulation of blood pressure
Neural regulation of energy metabolism
Renin angiotensin system
|Karyn Esser, Ph.D.
Professor and Associate Program Director, Institute of Myology
|Circadian rhythms and the molecular clock in skeletal muscle
Exercise and circadian rhythms
Molecular clock and myogenic transcription program
Skeletal muscle hypertrophy
Aging and circadian rhythms
Skeletal muscle structure and function
|Yun Kyoung Kang, Ph.D.
Research Assistant Professor
|Roles of RNA binding coregulators (RBM39, RBM14, TRIM21) in nutrient-dependent mitochondrial dynamics-mediated inter-tissue communication during age-induced immunosenescence with a focus on cancer and neurodegeneration|
|Hideko Kasahara, M.D., Ph.D.
|The function of Nkx2.5, an evolutionarily conserved NK2 class of homeobox transcription factor in mature cardiomyocytes.|
|Jaya P. Kolli, M.D.
Lecturer in Physiology
|Dr. Kolli teaches graduate-level courses in Renal and Cardiovascular Physiology.|
|S. Paul Oh, Ph.D.
|Genetic and molecular mechanisms for mammalian pattern formation.
Development of the vascular system, the asymmetrical pattern formation of visceral organs along the left-right axis and the vertebral patterning along the anterio-posterior axis during development.
|Mohan K. Raizada, Ph.D.
|Cellular and Molecular Mechanisms Involved in Brain Angiotensin Control of Cardiovascular Functions.
Genetic Targeting of the RAS for the Control of Hypertension.
|Peter P. Sayeski, Ph.D.
|Signal transduction, Jak2 tyrosine kinase, tyrosine kinase biology, small molecule inhibitors, myeloproliferative disorders, stroke, hematological malignancies.|
|Debbie A. Scheuer, Ph.D.
|Actions of glucocorticoids on neuronal function, neural control of the circulation, and myocardial ischemia.|
|Bruce R. Stevens, Ph.D.
|Gut Microbiome, Inflammation, Astrocyte, Transport, Transporter, Membranes, Schizophrenia, Psychosis, TLR3, Innate Immunity, Signaling, Cellular Physiology, Antioxidant, PKR, Heme oxygenase, Glutamate|
|Colin Sumners, Ph.D.
|The cellular, molecular and physiological actions of angiotensin II (Ang II) in the brain.|
|Tanja Taivassalo, Ph.D.
|Neuromuscular disease; Mitochondria and mitochondrial DNA disorders; Innovative treatment approaches aimed at inducing skeletal muscle adaptation; Exercise training; Intermittent hypoxia|
|Glenn A. Walter, Ph.D.
|Pathophysiology of muscle damage and the development of novel molecular and cellular imaging techniques|